Get an overview of various legacy and modular RCM solutions. Also, explore the defined end-users like hospitals and ambulatory physician practices, along with emerging business models, key challenges, and growth drivers, restraints, and opportunities.
How are advanced analytics and AI fueling innovation in this segment? How will new technologies help in achieving better healthcare outcomes? What are the future growth predictions? Who are the key stakeholders?
How are clinical trial decentralization and data-driven R&D creating new growth opportunities? What are the latest developments in value-based care? What are key areas for therapeutics? What are the new mergers and acquisitions?
The metaverse is the next step in the evolution of the internet and social media, according to Frost & Sullivan Research Director Kiran Kumar V. The metaverse is an interconnected network of virtual worlds that are shared and will serve as a new paradigm where our digital and physical lives converge. It refers to a three-dimensional virtual world where users can create content, trade and interact with each other through immersive experiences.
Many players define the metaverse as THE next revolution. At Frost & Sullivan, we compare it with our real physical universe, which is always expanding since its creation in the Big Bang. Meta (Facebook) rebranding and $10 billion in investments into metaverse development efforts look like this Big Bang. We strongly believe that the metaverse will expand in continuous waves. Radical evolutions of technologies and consumer behaviors will build a new universe as a whole—a kind of “meta-cosmos.” It will take time, but the process has already started and is irreversible.
Schedule a dialog or email us at myfrost@frost.com to connect with an industry expert at no charge. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.
What new technological capabilities are powering the future of this sector?
Read more Request Info
Explore competitive strategies designed by the key participants
Read more Request Info
What are the various approaches taken by Medtech companies to succeed?
Read more Request Info
How are automated robots enhancing the efficiency of various applications?
Read more Request Info
How will on-demand digital diagnostic services facilitate personalized healthcare?
Read more Request Info
How are changing regulations and consumerization opening new avenues of growth?
Read more Request Info
Examine the leading participants in this segment and their innovative growth strategies
Read more Request Info
Analyze the digital OR application areas and technologies that showcase high growth potential
Read more Request InfoBased on its recent analysis of the Indian in vitro diagnostics (IVD) market, Frost & Sullivan recognizes Roche Diagnostics India with the 2021 India Competitive Strategy Leadership Award for its well-executed country strategies, effective market penetration, and innovative offerings. Each year, Frost & Sullivan presents this award to the company that leverages competitive intelligence to successfully execute a strategy that results in stronger market share, competitive brand positioning, and customer satisfaction.
Read more
Based on its recent analysis of the global artificial intelligence (AI)-enabled drug discovery industry, Frost & Sullivan recognizes Insilico Medicine with the 2021 Entrepreneurial Company of the Year Award in the global AI-enabled drug discovery industry. Pharma.AI, the end-to-end AI-enabled drug discovery and development platform of Insilico, addresses challenges that touch on chemistry, biology, and digital medicine.
Read more
Philips’ products and solutions are aligned toward achieving its North Star—Quadruple Aim in Healthcare. Philips has committed significant resources to develop strategic tools, such as its vendor-neutral HealthSuite Platform, which will significantly expand the company’s solution portfolio and market reach and diversify its revenue base.
Read more
Transformational forces are influencing the global contract development and manufacturing organization (CDMO) market’s growth. Disruptive, innovative business models and technologies mandate the need to commercialize personalized therapies and focus on improvements in manufacturing technologies.
The global femtech market reached $707.6 million in 2021 and is expected to hit $1.15 billion by 2025, driven mainly by the demand from fertility, menopause and geriatric care. While the older demographic will be the largest market for this segment, the younger population is expected to drive the general health & wellness segment and embrace new technologies more enthusiastically.
As the impact of digitalization advances across all sectors, businesses are at a crucial turning point. They must optimize the returns from their existing resources while embracing new business models to create greater value for customers amid a challenging environment caused by the pandemic, geopolitical pressures and the supply chain crisis.
Read more
